In response to the growing demand for high-quality healthcare, Medicana Health Group is set to make a significant impact in the UK, introducing its acclaimed healthcare services.
Medicana Health Group, a pioneer in patient-focused healthcare solutions, is excited to announce its expansion into the UK, bringing its signature approach of personalised care and patient-centric services. This strategic move is designed to cater to the increasing shift towards private healthcare and insurance solutions, particularly evident in the post-pandemic period. Medicana is built on a foundation of “active listening and personalised attention,” aimed at thoroughly understanding and meeting the unique needs of each patient, thus ensuring a healthcare journey that is tailored from the first point of contact to aftercare, with the goal of transforming the private healthcare landscape in the UK.
Focusing on “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group is committed to providing an experience that is both intensely personal and carefully designed, leveraging their established model in Türkiye to bring about a significant change in the UK’s private healthcare industry.
Entering the £282 Billion UK Healthcare Marketplace
The revival of the UK’s private healthcare sector post-COVID has been primarily fueled by an increase in self-paying patients. More individuals than ever are turning to private healthcare to avoid the long waiting times associated with the NHS and to access the high-quality services and expertise of the independent sector. The Akeso report estimates that the UK’s healthcare expenditure in 2022 reached approximately £282 billion, with public spending making up about 80% and private spending around 20%.
In this growing market, Medicana aims to leverage its extensive expertise and comprehensive suite of care services to make a mark in the UK’s private healthcare landscape. By implementing its tested model of care, which includes advanced diagnostics and specialised treatments, Medicana is poised to meet the increasing demand for premium private healthcare. The group’s unwavering commitment to healthcare excellence, paired with its innovative approach to patient care, positions Medicana as a key player in meeting the healthcare needs of the UK.
Annually Serving Over 5.5 Million Patients
Medicana Health Group annually serves over 5.5 million patients globally, through its network of 16 hospitals equipped with significant bed capacities. This demonstrates their broad experience in providing high-quality care and their ability to meet the diverse needs of a global patient population. The expansion of Medicana Health Group into the UK market is anticipated to bring about a pivotal shift towards more empathetic, effective, and personalised healthcare solutions, heralding a new era in their commitment to improving patient welfare and raising healthcare standards worldwide.
With over three decades of experience, Medicana’s expertise spans a vast array of medical specialties, offering leading-edge services in areas such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Furthermore, since 2016, Medicana Health Group has expanded its educational initiatives, offering a wide range of educational programmes from preschool to university level, both domestically in Türkiye and internationally.
